Comparison of different injection sites effects for recombinant human interleukin
10.3760/cma.j.issn.1674-2907.2016.03.022
- VernacularTitle:不同部位注射重组人白介素的效果比较
- Author:
Juping QI
1
;
Mingyu YANG
;
Li YU
Author Information
1. 解放军总医院骨科五病区
- Keywords:
Recombinant human interleukin;
Subcutaneous injection;
Pain;
Adverse reaction
- From:
Chinese Journal of Modern Nursing
2016;22(3):379-380
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the efficacy and side effects of recombinant human interleukin by adopting abdominal subcutaneous injection method and the traditional deltoid subcutaneous injection method. Methods A total of 106 patients were admitted to either intervention group or control group by course of treatment. The patient of control group (5-8 course of treatment) adopted traditional deltoid injection method and the intervention group (1-4 course of treatment) received abdominal injection method (1 times a day and 14 days per course of treatment) . Then we observed the incidence of pain and local adverse reactions in patients with injection sites. Results In the intervention group patients was 22. 6% in the incidence of moderate to severe pain, and 14. 2% subcutaneous scleroma rate, 18. 9% local redness and swelling occurred rate, that all were lower than those of the control group (χ2 = 2. 80, 4. 71, 5. 22;P < 0. 05 ). Conclusions The implementation of abdominal subcutaneous injection can reduce the patient's pain, promote successful completion of treatment and deserve further clinical dissemination.
